Metastatic nasopharyngeal carcinoma: clinical study and therapeutic results of 95 cases;Les cancers métastatiques du nasopharynx : étude clinique et résultats thérapeutiques de 95 cas

Cancer/Radiotherapie

Volumn 10, Issue 8, 2006, Pages 545-549

  Khanfir, A ^a   Frikha, M ^a   Ghorbel, A ^a   Karray, H ^a   Drira, M M ^a   Daoud, J ^a  

^a HABIB BOURGUIBA HOSPITAL   (Tunisia)

Author keywords

Chemotherapy; Metastasis; Nasopharyngeal carcinoma; Radiotherapy

Indexed keywords

BLEOMYCIN; CISPLATIN; EPIRUBICIN; FLUOROURACIL;

ADULT; ARTICLE; BONE METASTASIS; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; COMPRESSION FRACTURE; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HIGH RISK PATIENT; HUMAN; KAPLAN MEIER METHOD; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METASTASIS; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TUMOR LOCALIZATION; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; BONE NEOPLASMS; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; EPIRUBICIN; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM METASTASIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33845294376     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2006.05.004     Document Type: Article

References (22)

1. Airoldi M., De Crescenzo A., Pedani F., Marchionatti S., Gabriele A.M., Succo G., et al. Feasibility and long-term results of autologous PBSC transplantation in recurrent undifferentiated nasopharyngeal carcinoma. Head Neck 23 (2001) 739-803
2. Azli N., Fandi A., Bachouchi M., Rahal M., Lianes P., Wibault P., et al. Final report of a phase II study of chemotherapy with bleomycin, epirubicin and cisplain for locally advanced and metastatic or recurrent undifferentiated carcinoma of the nasopharyngeal type. Cancer J. Sci. Am. 1 (1995) 222-229
3. Boussen H., Cvitkovic E., Wendling J.L., Azli N., Bachouchi M., Mahjoubi R., et al. Chemotherapy of metastatic and or recurrent undifferentiated nasopharygeal carcinoma with cisplatin, bleomycin and fluorouracil. J. Clin. Oncol. 9 (1991) 1675-1681
4. Chan A.T., Hsu M.M., Goh B.C., Hui E.P., Liu T.W., Millward M.J., et al. Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma. J. Clin. Oncol. 23 (2005) 7757-7758
5. Chua D.T., Sham J.S., and Au G.K. A phase II study of docetaxel and cisplatin as first-line chemotherapy in patients with metastatic nasopharyngeal carcinoma. Oral Oncol. 41 (2005) 589-595
6. Cohen Solal-Le Nir C., and Floiras J.L. Place de la radiothérapie dans le traitement des métastases osseuses. Bull. Cancer 79 (1992) 177-182
7. Daoud J., Toumi N., Bouaziz M., Ghorbel M., Jlidi R., Drira M.M., et al. Nasopharyngeal carcinoma in childhood and adolescence: analysis of a series of 32 patients treated with combined chemotherapy and radiotherapy. Eur. J. Cancer 39 (2003) 2349-2354
8. Ellouze R., Daoud J., and Maalej M. Cancers du nasopharyx. In: Maalej M. (Ed). Cancérologie Pratique (1999), centre de publication universitaire, Tunis 161-169
9. Fandi A., Bachouchi M., Azli N., Taama A., Boussen H., Wibault P., et al. Long-term disease-free survivors in metastatic undifferentiated carcinoma of the nasopharyngeal type. J. Clin. Oncol. 18 (2000) 1324-1330
10. Fandi A., Taamma A., Azli N., Bachouchi M., Yanes B., Armand J.P., et al. Palliative treatment with low-dose continuous 5-Fluorouracile in recurrent and or metastatic undifferentiated nasopharyngeal carcinoma type. Head Neck 19 (1997) 41-47
11. Fandi A., Yanes B., Taamma A., Azli N., Armand J.P., Dupuis O., et al. Carcinomes indifférenciés du nasopharynx: aspects épidémiologiques, cliniques et thérapeutiques. Bull. Cancer 81 (1994) 571-586
12. Foo K.F., Tan E.H., Leong S.S., Wee J.T.S., Tan T., Fong K.W., et al. Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type. Ann. Oncol. 13 (2002) 150-156
13. Hasbini A., Mahjoubi R., Fandi A., Couaki N., Taama A., Lianes P., et al. Phase II trial combining mitomycin with 5-fluorouracile, epirubicin and cisplatin in recurrent and metastatic undifferenciated carcinoma of nasopharyngeal type. Ann. Oncol. 10 (1999) 421-425
14. e Forum de cancérologie. Bull. Cancer 87 (2000) 423-428
15. Leong S.S., Wee J., Tay M.H., Toh C.K., Tan S.B., Thng C.H., et al. Paclitaxel, carboplatin and gemcitabine in metastatic nasopharyngeal carcinoma: a phase II trial using a triplet combination. Cancer 103 (2005) 569-575
16. Leung S.F., Tsao S.Y., and Shiu W. Treatment outcome of spinal cord compression by nasopharyngeal carcinoma. Br. J. Radiol. 63 (1990) 716-719
17. Lin J.C., Jian J.S., and Hsu C.Y. Outpatient weekly chemotherapy in patients with nasopharygeal carcinoma and distant metastastasis. Cancer 83 (1998) 635-640
18. Rivera S., Keryer C., Busson P., and Maignon P. Nasopharyngeal carcinomas: from biology to clinic. Cancer Radioth. (2005) 55-68
19. Roychowdhury D.F., Tseng Jr. A., Fu K.K., Weinberg V., and Weidner N. New Prognostic factors in Nasopharyngeal Carcinoma. Tumor angiogenesis and C-erb2. Cancer 77 (1996) 1419-1426
20. Siu L.L., Czaykowski P.M., and Tannock I.F. Phase I/II study of the CAPABLE for patients with poorly differentiated carcinoma of the nasopharynx. J. Clin. Oncol. 16 (1998) 2514-2521
21. Spano J.P., Busson P., Atlan D., Bourhis J., Pignon J.P., Esteban C., et al. Nasopharyngeal carcinoma: an update. Eur. J. Cancer 39 (2003) 2121-2135
22. Tan E.H., Khoo K.S., Wee J., Fong K.W., Lee K.S., Lee K.M., et al. Phase II trial of Paclitaxel and Carboplatin in Asian patients with metastatic nasopharyngeal carcinoma. Ann. Oncol. 10 (1999) 235-237